Jay Venkatesan - Insider Trading & Ownership

Entity: Individual
Location: C/O Ayer Capital Management, Lp, 230 California St, Suite 600, San Francisco, CA
Summary: The estimated net worth of Jay Venkatesan is at least $37.4M dollars as of April 10, 2025. Jay Venkatesan is the Director, 10%+ Owner of ALPINE IMMUNE SCIENCES, INC. and owns shares of ALPINE IMMUNE SCIENCES, INC. stock worth about $36.6M. Jay Venkatesan is the Director of Serina Therapeutics, Inc. and owns shares of Serina Therapeutics, Inc. (SER) stock worth about $500K. Jay Venkatesan is the Director of Elicio Therapeutics, Inc. and owns shares of Elicio Therapeutics, Inc. (ELTX) stock worth about $251K.
All Insider Reports: All Insider Reports

Ownership of Jay Venkatesan

Symbol	Company	Relationship	Holdings Value	Past Year Net Change	Change %	Report Period
ALPN	ALPINE IMMUNE SCIENCES, INC.	Director, 10%+ Owner	$36.6M			Jul 15, 2022
SER	Serina Therapeutics, Inc.	Director	$500K			Apr 8, 2025
ELTX	Elicio Therapeutics, Inc.	Director	$251K	+$250K	+13823%	Nov 26, 2024

Sym	Company	Class	Transaction	%	Value $	* Price $	Shares	Shares After	Date	Ownership

* An asterisk sign (*) next to the price indicates that the price is likely invalid.